A detailed history of Graham Capital Management, L.P. transactions in Personalis, Inc. stock. As of the latest transaction made, Graham Capital Management, L.P. holds 21,222 shares of PSNL stock, worth $73,428. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,222
Holding current value
$73,428
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.19 - $6.34 $25,254 - $134,547
21,222 New
21,222 $114,000
Q2 2022

Aug 15, 2022

SELL
$3.27 - $8.76 $10,755 - $28,811
-3,289 Reduced 6.38%
48,230 $166,000
Q1 2022

May 16, 2022

BUY
$7.56 - $14.3 $389,483 - $736,721
51,519 New
51,519 $421,000

Others Institutions Holding PSNL

About Personalis, Inc.


  • Ticker PSNL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 45,918,400
  • Market Cap $159M
  • Description
  • Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...
More about PSNL
Track This Portfolio

Track Graham Capital Management, L.P. Portfolio

Follow Graham Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Graham Capital Management, L.P. with notifications on news.